Table 4.
Univariate and multivariate logistic regression analyses of variables associated with advanced fibrosis (F>2) and cirrhosis (F>3) and C-statistics
Variable | Univariate | C-statistics | Model 1* | C-statistics | Model 2† | C-statistics | |||
---|---|---|---|---|---|---|---|---|---|
Multivariate | Multivariate | ||||||||
Odds ratio (95% CI) | P | Odds ratio (95% CI) | P | Odds ratio (95% CI) | P | ||||
F>2 | 0.95 (0.90–0.99) | 0.94 (0.90–0.98) | |||||||
M2BPGi | 9.572 (3.668–24.978) | < 0.001 | 0.87 (0.80–0.93) | 4.949 (1.424–17.196) | 0.012 | 5.187 (1.648–16.328) | 0.005 | ||
APRI | 3.500 (1.711–7.161) | 0.001 | 0.76 (0.68–0.84) | 0.658 (0.160–2.713) | 0.563 | ||||
FIB-4 | 4.043 (2.405–6.797) | < 0.001 | 0.92 (0.87–0.97) | 1.981 (0.677–5.795) | 0.212 | ||||
NFS | 3.860 (2.291–6.502) | < 0.001 | 0.92 (0.87–0.97) | 2.089 (0.905–4.819) | 0.084 | 3.376 (1.941–5.870) | < 0.001 | ||
F>3 | 0.95 (0.91–0.99) | 0.94 (0.90–0.98) | |||||||
M2BPGi | 5.818 (2.368–14.297) | < 0.001 | 0.90 (0.84–0.96) | 3.605 (1.111–11.701) | 0.033 | 3.244 (1.126–9.345) | 0.033 | ||
APRI | 1.270 (0.681–2.370) | 0.453 | 0.64 (0.55–0.73) | 0.054 (0.002–1.240) | 0.068 | ||||
FIB-4 | 1.787 (1.344–2.377) | < 0.001 | 0.89 (0.84–0.95) | 1.771 (0.821–3.822) | 0.145 | ||||
NFS | 3.114 (1.805–5.370) | < 0.001 | 0.93 (0.88–0.97) | 2.337 (0.999–5.467) | 0.050 | 2.533 (1.451–4.423) | 0.050 |
*Model 1 used M2BPGi, APRI, FIB-4, and NFS as independent variables; †Model 2 selected significant variables by a stepwise method using M2BPGi, APRI, FIB-4, and NFS as independent variables.
Abbreviations: APRI, aspartate aminotransferase to platelet ratio index; CI, confidence interval; F, fibrosis; FIB-4, fibrosis index based on four factors; M2BPGi, Mac-2 binding protein glycosylation isomer; NAFLD, non-alcoholic fatty liver disease; NFS, NAFLD fibrosis score.